Goldman Sachs
ARKG icon

Goldman Sachs’s ARK Genomic Revolution ETF ARKG Stock Holding History

Goldman Sachs’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127M Buy
3,016,963
+159,569
+6% +$5.08M 0.01% 1054
2026
Q1 		$75.5M Buy
2,857,394
+853,530
+43% +$25M 0.01% 1246
2025
Q4 		$58.1M Sell
2,003,864
-155,648
-7% -$4.67M 0.01% 1391
2025
Q3 		$60M Sell
2,159,512
-1,023,107
-32% -$25.9M 0.01% 1288
2025
Q2 		$77.5M Sell
3,182,619
-107,275
-3% -$2.35M 0.01% 1054
2025
Q1 		$68.3M Sell
3,289,894
-337,052
-9% -$8.47M 0.01% 1017
2024
Q4 		$85.4M Buy
3,626,946
+1,815,638
+100% +$44.7M 0.01% 900
2024
Q3 		$46.4M Buy
1,811,308
+904,573
+100% +$23M 0.01% 1308
2024
Q2 		$21.3M Buy
906,735
+560,674
+162% +$14.1M ﹤0.01% 1845
2024
Q1 		$9.95M Sell
346,061
-296,739
-46% -$8.92M ﹤0.01% 2465
2023
Q4 		$21.1M Buy
642,800
+469,740
+271% +$12.8M ﹤0.01% 1826
2023
Q3 		$4.82M Buy
173,060
+48,023
+38% +$1.57M ﹤0.01% 3007
2023
Q2 		$4.26M Sell
125,037
-785,711
-86% -$24.7M ﹤0.01% 3239
2023
Q1 		$27.4M Buy
910,748
+238,636
+36% +$7.39M 0.01% 1530
2022
Q4 		$19M Sell
672,112
-675,515
-50% -$21.4M ﹤0.01% 2020
2022
Q3 		$44.3M Buy
1,347,627
+694,636
+106% +$25.5M 0.01% 1199
2022
Q2 		$20.6M Sell
652,991
-1,181,680
-64% -$41.3M 0.01% 1867
2022
Q1 		$84.3M Buy
1,834,671
+1,172,438
+177% +$55.9M 0.02% 875
2021
Q4 		$40.6M Buy
662,233
+489,624
+284% +$33.8M 0.01% 1522
2021
Q3 		$12.9M Sell
172,609
-582,869
-77% -$48.9M ﹤0.01% 2468
2021
Q2 		$69.9M Buy
755,478
+396,398
+110% +$33.7M 0.02% 997
2021
Q1 		$31.9M Buy
359,080
+353,502
+6,337% +$35.1M 0.01% 1533
2020
Q4 		$520K Buy
+5,578
New +$444K ﹤0.01% 4585

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs's ARKG Position: Q2 2026 in Review

Goldman Sachs increased its ARK Genomic Revolution ETF (ARKG) stake by 5.6% in Q2 2026, buying an estimated $5.08M and bringing the position to 3,016,963 shares worth $127M. The position accounts for 0.01% of the portfolio, ranked #1054.

Goldman Sachs first reported a position in ARKG in Q4 2020 and has held it in 23 quarters since. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Goldman Sachs held 3,016,963 shares of ARK Genomic Revolution ETF worth $127M as of Q2 2026.
  • Goldman Sachs bought 159,569 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $5.08M.
  • ARK Genomic Revolution ETF made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1054 holding.
  • Goldman Sachs first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 23 quarters since.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.